Neurostimulant pharmaceutical drugs
PreclinicalSmall molecule
Neurostimulant pharmaceutical drugs is one of 7 small molecule programs targeting Attention. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Attention
#DrugCompanyPhaseTrials
1Ritalin
NovartisApproved
Tractocile
GSKPhase 1
Minipress
PfizerPreclinical
Pitressin
AAultman Health Foundation
Preclinical
Oxytocin Treatment
UUniversity of Electronic Science and Technology of China
Phase 1
Mecamylamine Pill
VVanderbilt University Medical Center
Phase 1
Neurostimulant pharmaceutical drugs
UUniversity of KwaZulu
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of KwaZulu